PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest
Figure 11.PCNT Knockdown promoted the cell cycle arrest in HCC cells. (A–C) Western blots images (A) and statistical analysis of CCNA2, CDK4, and CCND1 expression in HepG2 (B) and Hep3B (C) cell lines. *P < 0.05, **P < 0.01, ***P < 0.001.